Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

Diabetes Mellitus

Interventions

DRUG

Pioglitazone and insulin

Pioglitazone 30 mg, tablets, orally, once daily and variable insulin therapy for up to 24 weeks.

DRUG

Insulin

Pioglitazone placebo-matching tablets, orally, once daily and variable insulin therapy for up to 24 weeks.

Trial Locations (9)

Schwetzingen

Wiesbaden

Bottrop

Düsseldorf

Lüdenscheid

Solingen

Alzey

Ingelheim

Mainz